Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II

Annals of Thoracic Surgery

Volumn 69, Issue 3, 2000, Pages 774-777

  Christiansen, Stefan ^b   Jahn, Uli R ^a   Meyer, Jörg ^a   Scheld, Hans H ^a   Van Aken, Hugo ^a   Kehrel, Beate E ^a   Hammel, Dieter ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; DANAPAROID; HEPARIN; RECOMBINANT HIRUDIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG MEGADOSE; FEMALE; HEART ASSIST DEVICE; HEART DILATATION; HEART LEFT VENTRICLE PERFORMANCE; HEPARINIZATION; HUMAN; IMPLANT; ISCHEMIC HEART DISEASE; MALE; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; DRUG COMBINATIONS; FEMALE; HEART-ASSIST DEVICES; HEPARIN; HEPARITIN SULFATE; HIRUDIN THERAPY; HUMANS; MALE; MIDDLE AGED; THROMBOCYTOPENIA;

EID: 0034070052     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01423-X     Document Type: Article

References (21)

1. Kleinschmidt S., Seyfert U.T. Heparin-associated thrombocytopenia (HAT) - still a diagnostic and therapeutical problem in clinical practice. Angiology. 46:1995;37-44.
2. Jahn U.R., Thomitzek J., Ostermann H., Van Aken H., Meyer J. Heparin-induced thrombocytopenia in operative intensive care patients. AINS. 3:(Suppl):1998;403-404.
3. Altes A., Martino R., Gari M., et al. Heparin-induced thrombocytopenia and heart operation management with tedelparin . Ann Thorac Surg. 59:1995;508-509.
4. Robitaille D., Leclerc J.R., Laberge R., Sahab P., Atkinson S., Cartier R. Cardiopulmonary bypass with a low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia. J Thorac Cardiovasc Surg. 103:1992;597-599.
5. Teasdale S.J., Zulys V.J., Mycyk T., Baird R.J., Glynn M.F.X. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg. 48:1989;712-713.
6. Kappa J.R., Ellison N., Fisher C.A., Addonizio V.P. The use of iloprost (ZK 36374) to permit cardiopulmonary bypass in 2 patients with heparin-induced thrombocytopenia. Anesthesiology. 63:1985;A32.
7. Cannell P.K., Herrmann R.P., Marshall L. Heparinoid during cardiopulmonary bypass. Aust New Zealand J Med. 21:(Suppl 1):1991;141.
8. Christiansen S., Geiger A., Splittgerber F.H., Reidemeister J. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia. Int J Angiol. 7:1998;268-270.
9. Doherty D.C., Ortel T.L., de Bruijn N., Greenberg C.S., van Trigt P. "Heparin-free" cardiopulmonary bypass first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass . Anesthesiology. 73:1990;562-565.
10. Scheffler E., Aulmann M., Remppis A., et al. Successful use of the heparinoid danaparoid-sodium during aortic valve prosthesis replacement in a patient with heparin-induced thrombocytopenia type II. Z Kardiol. 84:1995;565-568.
11. Riess F., Pötzsch B., Bader R., et al. A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery. Eur J Cardiothorac Surg. 10:1996;386-388.
12. Loebe M., Hennig E., Müller S., Spiegelsberger S., Weng Y., Hetzer R. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy and for permanent replacement. Eur J Cardiothorac Surg. 11:(Suppl):1997;18-24.
13. Rose E.A., Levin H.R., Oz M.C., et al. Artificial circulatory support with textured interior surfaces. Circulation. 90:1994;II87-II91.
14. Copeland J.G. Thromboembolism and bleeding clinical strategies . Ann Thorac Surg. 61:1996;376-377.
15. Scheld H.H., Hammel D., Schmid C., et al. Beating heart implantation of a wearable Novacor left-ventricular assist device. Thorac Cardiovasc Surg. 44:1996;62-66.
16. Spanier T., Oz M., Levin H., et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg. 112:1996;1090-1097.
17. Scheld H.H. Mechanical support - benefits and risks. Thorac Cardiovasc Surg. 45:1997;1-5.
18. Graham T.R., Dasse K., Coumbe A., et al. Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device. Eur J Cardiothorac Surg. 4:1990;182-190.
19. Livingston E.R., Fisher C.A., Pathak A.S., et al. Increased acti-vation of the coagulation and fibrinolytic systems in left ventricular assist device recipients may lead to hemorrhagic complications. [Abstract] Circulation. 92:(Suppl I):1995;I50.
20. Chong B.H., Magnani H.N. Orgaran in heparin-induced thrombocytopenia. Haemostasis. 22:1992;85-91.
21. Sandset P.M., Abildgaard U., Larsen M.L. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res. 50:1988;803-813.